Cargando…

Staphylococcus aureus is able to generate resistance to novel lipoglycopeptide antibiotic gausemycin A

Gausemycin A is the first member of the novel lipoglycopeptides family produced by Streptomyces roseoflavus INA-Ac-5812. Gausemycin A has a pronounced bactericidal activity against methicillin-resistant Staphylococcus aureus. However, the ability of S. aureus to be resistant to gausemycin A has not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poshvina, Darya V., Dilbaryan, Diana S., Kasyanov, Sergey P., Sadykova, Vera S., Lapchinskaya, Olda A., Rogozhin, Eugene A., Vasilchenko, Alexey S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558223/ https://www.ncbi.nlm.nih.gov/pubmed/36246291 http://dx.doi.org/10.3389/fmicb.2022.963979

Ejemplares similares

Gausemycin A-Resistant Staphylococcus aureus Demonstrates Affected Cell Membrane and Cell Wall Homeostasis
por: Poshvina, Darya V., et al.
Publicado: (2023)

A Novel Peptide Antibiotic Produced by Streptomyces roseoflavus Strain INA-Ac-5812 With Directed Activity Against Gram-Positive Bacteria
por: Vasilchenko, Alexey S., et al.
Publicado: (2020)

VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae Cells
por: Vimberg, Vladimir, et al.
Publicado: (2020)

Telavancin: A novel lipoglycopeptide antibiotic
por: Damodaran, S. E., et al.
Publicado: (2011)

2,4-Diacetylphloroglucinol Modulates Candida albicans Virulence
por: Stepanov, Artyom A., et al.
Publicado: (2022)

Bacterial-Derived Plant Protection Metabolite 2,4-Diacetylphloroglucinol: Effects on Bacterial Cells at Inhibitory and Subinhibitory Concentrations
por: Julian, William T., et al.
Publicado: (2020)

Sub-inhibitory Effects of Antimicrobial Peptides
por: Vasilchenko, Alexey S., et al.
Publicado: (2019)

Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections
por: Plaunt, Adam J., et al.
Publicado: (2021)

Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
por: Zhang, Rutan, et al.
Publicado: (2021)

Two Novel Semisynthetic Lipoglycopeptides Active against Staphylococcus aureus Biofilms and Cells in Late Stationary Growth Phase
por: Vimberg, Vladimir, et al.
Publicado: (2021)

Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics
por: Sur, Vishma Pratap, et al.
Publicado: (2021)

Draft Genome Sequence of the Multiple Antibiotic Producer Bacillus velezensis X-BIO-1
por: Kravchenko, S. V., et al.
Publicado: (2020)

Commentary: Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
por: Meredith, Emily M., et al.
Publicado: (2021)

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
por: Brade, Karrine D., et al.
Publicado: (2016)

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
por: Kussmann, Manuel, et al.
Publicado: (2018)

Engineered biosynthesis of enduracidin lipoglycopeptide antibiotics using the ramoplanin mannosyltransferase Ram29
por: Wu, Ming-Cheng, et al.
Publicado: (2015)

Nigellothionins from Black Cumin (Nigella sativa L.) Seeds Demonstrate Strong Antifungal and Cytotoxic Activity
por: Barashkova, Anna S., et al.
Publicado: (2021)

A Novel Lipopeptaibol Emericellipsin A with Antimicrobial and Antitumor Activity Produced by the Extremophilic Fungus Emericellopsis alkalina
por: Rogozhin, Eugene A., et al.
Publicado: (2018)

Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections
por: Smith, Jordan R., et al.
Publicado: (2015)

Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs
por: Morrisette, Taylor, et al.
Publicado: (2019)

Peptide Extracts from Seven Medicinal Plants Discovered to Inhibit Oomycete Phytophthora infestans, a Causative Agent of Potato Late Blight Disease
por: Rogozhin, Eugene A., et al.
Publicado: (2020)

Draft Genome Sequence of Pseudomonas brassicacearum Strain UTMN3, a Biological Control Agent from the Rhizosphere of Pisum sativum
por: Poshvina, D. V., et al.
Publicado: (2021)

Triazoles and Strobilurin Mixture Affects Soil Microbial Community and Incidences of Wheat Diseases
por: Vasilchenko, Anastasia V., et al.
Publicado: (2023)

Impact of the new membrane-targeting lipoglycopeptide antibiotic MCC5145 on the treatment of bacteremic pneumococcal pneumonia in mice
por: Ogunniyi, Abiodun D., et al.
Publicado: (2023)

Complete Genome Sequences of Streptomyces albus Strain INA 01303
por: Poshvina, D. V., et al.
Publicado: (2022)

Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics
por: Eckmann, Christian, et al.
Publicado: (2021)

Atomic force microscopy recognition of protein A on Staphylococcus aureus cell surfaces by labelling with IgG–Au conjugates
por: Tatlybaeva, Elena B, et al.
Publicado: (2013)

Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
por: Jafari Saraf, Lida, et al.
Publicado: (2011)

231. Retrospective Comparison of Intravenous Therapy, Oral Therapy, and Lipoglycopeptides for the Treatment of Osteomyelitis
por: Stumphauzer, Alex, et al.
Publicado: (2021)

Isolation of Staphylococcus aureus and Antibiotic-Resistant Staphylococcus aureus from Residential Indoor Bioaerosols
por: Gandara, Angelina, et al.
Publicado: (2006)

MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide
por: Du, Jing-Jing, et al.
Publicado: (2022)

Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
por: Guo, Yunlei, et al.
Publicado: (2020)

Antibiotic combinations reduce Staphylococcus aureus clearance
por: Lázár, Viktória, et al.
Publicado: (2022)

Primary Structure Analysis of Antifungal Peptides from Cultivated and Wild Cereals
por: Rogozhin, Eugene, et al.
Publicado: (2018)

Staphylococcus aureus Keratitis in Taiwan: Genotyping, Antibiotic Susceptibility, and Clinical Features
por: Hsiao, Ching-Hsi, et al.
Publicado: (2022)

The Emericellipsins A–E from an Alkalophilic Fungus Emericellopsis alkalina Show Potent Activity against Multidrug-Resistant Pathogenic Fungi
por: Kuvarina, Anastasia E., et al.
Publicado: (2021)

617. Long Acting Lipoglycopeptide Use in Veterans for Serious Gram-Positive Infections in the COVID Era
por: Saldana, Carlos S, et al.
Publicado: (2021)

Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection
por: Konicek, Donna M., et al.
Publicado: (2023)

Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria
por: Shittu, Adebayo O, et al.
Publicado: (2011)

Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections
por: Nadrah, Kristina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_759gkhgir2uunrvfqotglenldv